Explore
Validate
LearnV3021
antibody from NSJ Bioreagents
Targeting: CD59
16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20
Immunocytochemistry
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V3021 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- CD59 Antibody
- Antibody type
- Monoclonal
- Antigen
- Human K562 tumor cells were used as the immunogen for the CD59 antibody.
- Description
- Protein G purified antibody
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- BRA-10G
- Vial size
- 20 µg, 100 µg (with sodium azide), 100 µg (without sodium azide), 7 ml (prediluted for IHC use, if applicable)
- Storage
- Store the CD59 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
Submitted references Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubes.
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity.
Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody.
Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.
Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies.
Arkwright PD, Luchetti F, Tour J, Roberts C, Ayub R, Morales AP, RodrÃguez JJ, Gilmore A, Canonico B, Papa S, Esposti MD
Cell research 2010 Jan;20(1):72-88
Cell research 2010 Jan;20(1):72-88
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity.
Natsume A, Shimizu-Yokoyama Y, Satoh M, Shitara K, Niwa R
Cancer science 2009 Dec;100(12):2411-8
Cancer science 2009 Dec;100(12):2411-8
Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody.
Fritzinger AE, Toney DM, MacLean RC, Marciano-Cabral F
Infection and immunity 2006 Feb;74(2):1189-95
Infection and immunity 2006 Feb;74(2):1189-95
Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope.
Magre S, Takeuchi Y, Langford G, Richards A, Patience C, Weiss R
Journal of virology 2004 Jun;78(11):5812-9
Journal of virology 2004 Jun;78(11):5812-9
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Clayton A, Harris CL, Court J, Mason MD, Morgan BP
European journal of immunology 2003 Feb;33(2):522-31
European journal of immunology 2003 Feb;33(2):522-31
Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.
Zhang J, Gerhardinger C, Lorenzi M
Diabetes 2002 Dec;51(12):3499-504
Diabetes 2002 Dec;51(12):3499-504
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.
Clayton A, Court J, Navabi H, Adams M, Mason MD, Hobot JA, Newman GR, Jasani B
Journal of immunological methods 2001 Jan 1;247(1-2):163-74
Journal of immunological methods 2001 Jan 1;247(1-2):163-74
Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies.
Olafsen T, Munthe Lund CK, Bruland OS, Sandlie I, Michaelsen TE
Cancer immunology, immunotherapy : CII 1999 Oct;48(7):411-8
Cancer immunology, immunotherapy : CII 1999 Oct;48(7):411-8
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- SDS-PAGE Analysis of Purified, BSA-Free CD59 Antibody (clone BRA-10G). Confirmation of Integrity and Purity of the Antibody.
